FundedIQ
Health Care

CosmoAesthetics

CosmoAesthetics, a company founded in 2015, focuses on the creation and marketing of a variety of devices using Low Level Light Technology (LLLT), a form of light that has been shown to be safe and to have therapeutic and aesthetic effects when used at specified levels.

cosmoinnovations.com.au Kew, Australia 1-10 employees
Total raised
$6.0M
Latest round: +100% of prior total
Rounds
2
Latest
Seed
May 2025

CosmoAesthetics, a company founded in 2015, focuses on the creation and marketing of a variety of devices using Low Level Light Technology (LLLT), a form of light that has been shown to be safe and to have therapeutic and aesthetic effects when used at specified levels.

CosmoAesthetics has raised $6.0M across 2 rounds. Its most recent round was a Seed of $3.0M in May 2025. Full funding history, investors, and team are detailed below.

Funding history

2 rounds · 1 visible Unlock with plan

2 rounds on record — latest round shown, the rest unlock with a paid plan.

Date
Round
Amount
Lead investor
May 1, 2025
Seed
$3.0M

Unlock 1 earlier round — dates, amounts, round types — plus the lead investor for every round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

CosmoAesthetics is featured in

Similar companies

Saluda Medical

In 2013, Saluda Medical was founded with the objective of transforming four years of investigation from NICTA, a top-class information communications technology hub in Australia, into a profitable endeavor. The personnel of the firm comprises engineers, medical practitioners, and seasoned experts who have a track record of successfully launching medical technologies.

Venture - Series Unknown $30.0M
Venstra Medical

VenstraMedical develop and commercialise percutaneous circulatory support systems for temporary use by cardiologists in the treatment of patients requiring cardiac support without surgical intervention.

Series Unknown $650k
CathRx

CathRx focuses on creating and producing electrophysiology catheters used to diagnose and treat cardiac arrhythmias.

Series Unknown $710k
Mixed Martial Arts Group

Mixed Martial Arts Group is a company that specializes in technology and concentrates on the worldwide combat sports industry.

Series Unknown $3.3M
Botanix Pharmaceuticals

Botanix Pharmaceuticals is dedicated to improving the lives of patients with skin diseases such as acne, psoriasis, and atopic dermatitis. The company aims to provide new treatment options for these conditions, which are currently not effectively addressed or have side effects from existing therapies. Botanix is exploring the potential of synthetic cannabidiol, a pharmaceutical ingredient being researched for various medical uses, including epilepsy, pain, arthritis, and schizophrenia. The company is now getting ready to conduct human trials using synthetic cannabidiol in their unique drug delivery system, PermetrexTM, for direct application to the skin.

Series Unknown $20.2M
Five Faces

Blue-chip companies use the Five Faces platform to improve customer experiences through centrally managed content on various digital devices. The platform has also been tailored for use in healthcare facilities to meet their specific needs. Five Faces believes in providing positive healthcare experiences by making information easily accessible and aims to revolutionize healthcare communications. The company's digital solutions are implemented in numerous sites across different regions and have received awards for their visibility, efficiency, and ongoing service.

Series A $650k
Neurode

Neurode is creating a non-invasive wearable technology that enhances cognitive function for individuals with neurological disorders such as ADHD. This device, along with an accompanying app, is designed to both manage and monitor the symptoms of ADHD, while also tracking progress and sharing results with healthcare providers.

Seed $10.0M
Sonder

Sonder is the trusted wellbeing partner for some of the world’s most innovative organisations as they reimagine how to care and support their people. With a clear purpose of breaking down barriers to help, providing the right support to people at the right time. Acknowledging that there are often multiple factors at play, and wellbeing comprises of cultural, social, environmental and vocational factors, all which play a part in getting to the root cause of issues, and on a path to wellness. The heart of Sonder's solution is a technology-driven platform supported in real time by medical and mental health experts - experts that are available every minute of every day. Their mission is to get the right outcome across any wellbeing or safety issue. Trusted by major corporations, education providers and Government to enhance wellbeing across the world, Sonder is on a mission to create a better world, accepting differences and supportive of others. A world where it's OK to ask for help, for anything, at any time of the day or night. It takes humans to help other humans. That’s why Sonder combines a human first, tech supported approach.

Series Unknown $25.3M
Amelio Health

Amelio Health offers pain management services for individuals suffering from chronic pain.

Series Unknown $400k
Splose

Splose is delightful software for Allied Health Practitioners & NDIS Providers - The smarter way to support clients, reduce admin, keep your team happy and grow your practice. Try Splose free with all features and integrations, like Xero, Stripe, NDIS, Medipass, Zoom and more!

Series Unknown $3.2M
Umps Health

Umps enables efficient, proactive, data-driven care at home. Our proprietary platform, the Umps Link: - Collects clinical and behavioural data from a person’s home in real-time through non-intrusive sensors. - Generates contextual insights into declines in health and wellbeing using AI. - Shares these insights with a real person, monitoring our enabling proactive health interventions. To users, Umps is a Personal Health Companion that supports independence and wellbeing at home. To health and aged care providers, Umps is an enterprise software application that empowers people to deliver high quality care efficiently.

Series A $4.0M
Cambium Bio

Cambium Medical Technologies, founded by four blood industry luminaries out of Emory University, Atlanta, Georgia (USA)--is focused on the development and commercialization of regenerative therapies derived from novel processed human platelets. Cambium is developing Elate Ocular a standardized, commercialized platelet derived biologic eye drop for dry eye syndrome (keratoconjunctivis sicca) as its first FDA approved therapy. Elate Ocular is an investigational drug and is not yet approved for sale in or outside the United States.

Series Unknown $1.9M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.